Century Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
![]() CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() ERAS
Erasca, Inc. |
$2.67 | $647.94 M | -2.83 | 126 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
![]() GBIO
Generation Bio Co. |
$1.14 | $216.88 M | -1.28 | 174 | $5.90 M |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
![]() KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
![]() LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() NGM
NGM Biopharmaceuticals, Inc. |
$1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
![]() NKTX
Nkarta, Inc. |
$2.46 | $465.09 M | -2.81 | 159 | $0 |
![]() PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
![]() RLAY
Relay Therapeutics, Inc. |
$4.57 | $1.05 B | -3 | 261 | $10.01 M |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
![]() THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |